Hvivo lands £5.2m contract with Asia-Pacific biotech to test RSV vaccine
This is the first human challenge trial contract Hvivo has signed with a client in the Asia-Pacific region in more than a decade.
Read more: Hvivo lands £5.2m contract with Asia-Pacific biotech to test RSV vaccine
